Cormorant Asset Management, LP → Erasca, Inc. ERAS

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 7.27

29,953,849 shares short · -2.6% vs prior

Other Filings by Cormorant Asset Management, LP

Filed	Form	Issuer	Stake	Shares
2026-08-13	SCHEDULE 13D	BlossomHill Therapeutics, Inc.	11.80%	959,090	view →
2025-10-10	SCHEDULE	Biomea Fusion, Inc. BMEA	5.31%	3,681,664	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →